Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group - Tsukimoto, I; Tawa, A; Horibe, K (J Clin Oncol, 2009)
et al.